Skip to Main Content

Paper Details

Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature.
Neurooncol Adv
2
2022
BRAF, HGG, High-grade gliomas, MEK, PDs, V600E, V600E mutations, anaplastic ganglioglioma, central nervous system tumors, dabrafenib, grade, grade 3, high-grade glioma, patient, patients, pleomorphic xanthoastrocytoma, trametinib
Author NameAffiliation
Nada JabadoMcGill University Health Center, Montreal Children's Hospital
Nada JabadoMcGill University Health Center, Montreal Children's Hospital
  • 1 - 2

Datasets

Release 1.2